Dying for drugs: Drug companies should swear “Hippocratic” oath

BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7410.343-b (Published 07 August 2003) Cite this as: BMJ 2003;327:343
  1. Swethajit Biswas, specialist registrar in medical oncology (bizs202@hotmail.com)
  1. Oncology Centre, Addenbrooke's Hospital, Cambridge CB2 2QQ

    EDITOR—Aronson's review of the television programme Dying for Drugs shows that the relation between medicine and drug companies is multifaceted.1 As a clinician you cannot practise without them, but at times you want to get rid of them for being unfaithful to your patients.

    With the current academic …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription